Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
GRI Bio, Inc. (GRI) had Normalized Income after Taxes of $-2.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.00M |
|
-- |
|
-- |
|
$2.00M |
|
$-2.00M |
|
$0.01M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
|
Normalized Income after Taxes |
$-2.00M |
$-2.00M |
|
$-2.00M |
|
1.24M |
|
1.24M |
|
$-1.61 |
|
$-1.61 |
|
| Balance Sheet Financials | |
$11.28M |
|
$0.00M |
|
$0.06M |
|
$11.34M |
|
$0.79M |
|
-- |
|
-- |
|
$0.79M |
|
$10.54M |
|
$10.54M |
|
$10.54M |
|
1.58M |
|
| Cash Flow Statement Financials | |
$-3.69M |
|
-- |
|
$6.50M |
|
$8.23M |
|
$11.05M |
|
$2.82M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.95% |
|
-18.95% |
|
-17.62% |
|
-18.95% |
|
$6.65 |
|
$-2.97 |
|
$-2.97 |
|